GSK to stop selling blood cancer drug Blenrep in US

LONDON, Nov 22 — GSK will stop selling its blood cancer drug Blenrep in the United States, it said today, representing the latest in a series of setbacks for the British...

Related Keywords

United States ,United Kingdom ,London ,City Of ,British ,Sabine Luik ,European Union ,Drug Administration ,Reuters ,Medical Officer Sabine Luik ,Glaxosmithkline Gsk ,Clinical Trials ,Blenrep ,Cancer Drug ,